RenaissanceRe (NYSE:RNR) Upgraded by Cantor Fitzgerald to Overweight Rating

Cantor Fitzgerald upgraded shares of RenaissanceRe (NYSE:RNR) from a neutral rating to an overweight rating in a report released on Thursday, MarketBeat.com reports. They currently have $340.00 price objective on the insurance provider’s stock, up from their prior price objective of $306.00.

A number of other analysts have also recently weighed in on the stock. Weiss Ratings restated a “buy (b)” rating on shares of RenaissanceRe in a research note on Friday, March 27th. Citigroup boosted their price objective on shares of RenaissanceRe from $328.00 to $333.00 and gave the stock a “neutral” rating in a research note on Wednesday, February 18th. Wall Street Zen upgraded shares of RenaissanceRe from a “hold” rating to a “buy” rating in a research note on Saturday, February 14th. JPMorgan Chase & Co. upped their target price on shares of RenaissanceRe from $303.00 to $329.00 and gave the company a “neutral” rating in a research note on Wednesday, January 7th. Finally, Barclays upped their target price on shares of RenaissanceRe from $310.00 to $341.00 and gave the company an “equal weight” rating in a research note on Wednesday. Three analysts have rated the stock with a Buy rating, fourteen have issued a Hold rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat.com, the stock presently has an average rating of “Hold” and an average target price of $309.50.

RenaissanceRe Price Performance

Shares of RenaissanceRe stock opened at $309.87 on Thursday. The firm has a fifty day simple moving average of $297.92 and a 200-day simple moving average of $276.20. The company has a current ratio of 1.43, a quick ratio of 1.43 and a debt-to-equity ratio of 0.21. RenaissanceRe has a 1-year low of $222.75 and a 1-year high of $315.88. The stock has a market capitalization of $13.37 billion, a price-to-earnings ratio of 5.47, a PEG ratio of 0.71 and a beta of 0.24.

RenaissanceRe (NYSE:RNR) last issued its quarterly earnings data on Tuesday, February 3rd. The insurance provider reported $13.34 earnings per share for the quarter, topping analysts’ consensus estimates of $10.59 by $2.75. RenaissanceRe had a net margin of 20.88% and a return on equity of 18.29%. The business had revenue of $2.97 billion during the quarter, compared to analysts’ expectations of $1.73 billion. During the same period in the previous year, the company earned $8.06 earnings per share. RenaissanceRe’s revenue for the quarter was up 29.6% on a year-over-year basis. On average, sell-side analysts expect that RenaissanceRe will post 26.04 earnings per share for the current year.

RenaissanceRe Increases Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Tuesday, March 31st. Stockholders of record on Friday, March 13th were paid a $0.41 dividend. The ex-dividend date was Friday, March 13th. This represents a $1.64 dividend on an annualized basis and a dividend yield of 0.5%. This is a positive change from RenaissanceRe’s previous quarterly dividend of $0.40. RenaissanceRe’s dividend payout ratio is currently 2.89%.

Insider Activity

In other news, EVP Robert Qutub sold 5,000 shares of the stock in a transaction on Friday, February 6th. The shares were sold at an average price of $305.75, for a total value of $1,528,750.00. Following the completion of the transaction, the executive vice president owned 73,023 shares in the company, valued at approximately $22,326,782.25. This represents a 6.41% decrease in their position. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. Corporate insiders own 2.30% of the company’s stock.

Hedge Funds Weigh In On RenaissanceRe

A number of hedge funds have recently made changes to their positions in the business. Capital World Investors raised its stake in shares of RenaissanceRe by 0.3% in the 3rd quarter. Capital World Investors now owns 2,649,518 shares of the insurance provider’s stock valued at $672,792,000 after buying an additional 7,839 shares in the last quarter. Boston Partners raised its stake in shares of RenaissanceRe by 9.9% in the 4th quarter. Boston Partners now owns 1,423,483 shares of the insurance provider’s stock valued at $400,150,000 after buying an additional 128,245 shares in the last quarter. Dimensional Fund Advisors LP raised its stake in shares of RenaissanceRe by 3.2% in the 4th quarter. Dimensional Fund Advisors LP now owns 1,033,009 shares of the insurance provider’s stock valued at $290,450,000 after buying an additional 31,599 shares in the last quarter. Lightrock Netherlands B.V. raised its stake in shares of RenaissanceRe by 4,690.1% in the 4th quarter. Lightrock Netherlands B.V. now owns 1,017,508 shares of the insurance provider’s stock valued at $286,083,000 after buying an additional 996,266 shares in the last quarter. Finally, Bank of America Corp DE raised its stake in shares of RenaissanceRe by 17.6% in the 2nd quarter. Bank of America Corp DE now owns 803,547 shares of the insurance provider’s stock valued at $195,182,000 after buying an additional 120,063 shares in the last quarter. Institutional investors and hedge funds own 99.97% of the company’s stock.

Key Stories Impacting RenaissanceRe

Here are the key news stories impacting RenaissanceRe this week:

• Positive Sentiment: Cantor Fitzgerald upgraded RNR from Neutral to Overweight and raised its target to $340, signaling meaningful upside and helping support the rally. Cantor Fitzgerald Upgrade (Benzinga) Finviz
• Positive Sentiment: Barclays raised its price target sharply to $341 (from $310) while keeping an Equal Weight rating — a sizable lift to consensus targets that likely boosted investor optimism. Barclays PT Raise (Benzinga)
• Positive Sentiment: UBS bumped its target to $319 and reiterated a Neutral view, adding incremental upward pressure on the stock by increasing modeled value. UBS PT Raise (Benzinga)
• Positive Sentiment: Keefe, Bruyette & Woods published a note forecasting strong price appreciation for RNR, which reinforces buy-side thesis around underwriting leverage and capital return. Keefe, Bruyette & Woods Forecast
• Positive Sentiment: Zacks / industry commentary highlighted RNR among P&C insurers positioned to benefit from digitalization and pricing tailwinds after catastrophe activity — a sector-level bullish signal for premiums and renewals. Zacks Industry Outlook (Yahoo)
• Positive Sentiment: A Zacks piece listing “5 Stocks to Add From the Prospering P&C Insurance Industry” included RNR, reinforcing positive thematic interest from value and sector investors. Zacks: 5 P&C Stocks
• Neutral Sentiment: Zacks published an analysis asking whether value investors should buy RNR, providing balanced coverage that may attract research-driven flows but not an explicit buy signal. Zacks Stock Analysis
• Neutral Sentiment: AmericanBankingNews noted that brokerages’ consensus rating is roughly a “Hold,” which caps upside expectations until more positive revisions arrive. Brokerage Consensus (AmericanBankingNews)
• Neutral Sentiment: CNN Markets maintains a standard company profile page for RNR (useful for quote/activity context but not new directional news). CNN Markets: RNR
• Negative Sentiment: Wells Fargo trimmed its price target slightly from $306 to $305 and kept an Equal Weight rating — a modest negative signal that partially offsets the bullish broker activity. Wells Fargo PT Cut (Benzinga)

RenaissanceRe Company Profile

RenaissanceRe Holdings Ltd. is a global provider of reinsurance and insurance solutions, specializing in property catastrophe, casualty, and specialty lines. Established in 1993 and headquartered in Bermuda, the company trades on the New York Stock Exchange under the symbol RNR. With a focus on underwriting and risk assessment, RenaissanceRe offers tailored programs designed to help insurers and corporations manage exposure to natural disasters, liability claims, and other complex risks.

The company operates through two primary segments: Reinsurance and Insurance.